Treatment of Prostate Cancer With Firmagon®

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

September 24, 2015

Conditions

Prostate Cancer

Interventions

DRUG

Degarelix

subcutaneous injection

Trial Locations (1)

UCM GmbH, Planegg

All Listed Sponsors

lead

United Clinic Management GmbH

INDUSTRY

NCT01710098 - Treatment of Prostate Cancer With Firmagon® | Biotech Hunter | Biotech Hunter